Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05898334 · ClinicalTrials.gov registry record · NA
Impact of Biophoton Generator on Chronic-Stroke Patients' Recovery
A NA study, sponsored by First Institute of All Medicines.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT05898334 is a NA study that has completed, run by First Institute of All Medicines. The registered enrollment target is 48 participants.
The verdict
NCT05898334, a NA study, has completed, sponsored by First Institute of All Medicines.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this clinical research is to verify if the patients with chronic stroke can regain the ability of living independently after daily using Testa BioHealing® Biophoton Generators to increase the energy of the brain and other parts of the body. The main study questions are: * Can patients with chronic stroke regain life independence by normalizing Activities of Daily Living (ADL). * Can brain-injury and recovery status of the patients with chronic stroke be detected by using an EEG machine. Participants will sleep-rest on a hotel bed energized by Tesla BioHealing Biophoton Generators, and clinical study staff will observe the participant's activities of daily living, as compared to those who will sleep in the hotel room equipped with placebo devices.
Interventions
- DEVICE Active Biophoton Generators
- DEVICE Inactive Biophoton Generators
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2023-05-10 |
| Est. Completion | 2024-06-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05898334
The ClinicalTrials.gov registry entry for NCT05898334 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is First Institute of All Medicines, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active Biophoton Generators is the first listed.
NCT05898334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05898334 about?
NCT05898334 is a clinical study titled "Impact of Biophoton Generator on Chronic-Stroke Patients' Recovery". The purpose of this clinical research is to verify if the patients with chronic stroke can regain the ability of living independently after daily using Testa BioHealing® Biophoton Generators to increase the energy of the brain and other parts of the body. The main study questions are: * Can patient...
What is the current status of trial NCT05898334?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2023-05-10. Estimated completion is 2024-06-28.
What interventions are being tested in trial NCT05898334?
The interventions under investigation include: Active Biophoton Generators (DEVICE), Inactive Biophoton Generators (DEVICE).
Who is sponsoring clinical trial NCT05898334?
This trial is sponsored by First Institute of All Medicines, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.